David C. Socol, M.D.

Dr. Socol practiced Occupational & Environmental Medicine at the Boeing Corporation for 17 years after working as the medical director for a nascent biotechnology company in Long Beach, California and medical director at US Healthworks (now Concentra) in the City of Industry, California.  While at Boeing, Dr. Socol began his medical education and fellowship training in Age Management Medicine at the Cenegenics Medical Institute, which was followed several years later by additional education in the treatment of mild traumatic brain injury (mTBI) and neurodegenerative disease in 2018.  In 2019, Dr. Socol completed training in functional genomics with a focus on precision medicine applications in medical, brain and mental health domains on behalf of his patients with traumatic brain injury.  He presently integrates genomics across nearly all of his patient base.

Dr. Socol founded Socol MD in 2017 to support mTBI treatment in the veteran community while continuing to work on behalf of Cenegenics in Beverly Hills, California.

Dr. Socol returned to the biotechnology world in early 2020 during the early days of the American SARS-CoV-2 outbreak to continue the development of technologies that were started 20 years prior.  While developing advanced concepts in clinical humeomics, Dr. Socol trained physicians across the United States